Skip to Main content Skip to Navigation
Journal articles

Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma a phase II LYSA study

Document type :
Journal articles
Complete list of metadatas

Cited literature [5 references]  Display  Hide  Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01903056
Contributor : Laurent Jonchère <>
Submitted on : Tuesday, November 13, 2018 - 11:15:31 AM
Last modification on : Tuesday, June 23, 2020 - 9:14:24 AM

File

Houot_Obinutuzumab plus Lenali...
Files produced by the author(s)

Identifiers

Citation

Roch Houot, Guillaume Cartron, Fontanet Bijou, Sophie de Guibert, Gilles A Salles, et al.. Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma a phase II LYSA study. Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2019, 33 (3), pp.776-780. ⟨10.1038/s41375-018-0282-y⟩. ⟨hal-01903056⟩

Share

Metrics

Record views

511

Files downloads

518